CNBC's Angelica Peebles talks to Roche Pharma CEO Teresa Graham discusses why we're still in the early stages of the obesity ...

HK inno.N markets Roches Avastin for cancer treatment in South Korea HK inno.N and Roche forge collaboration to boost cancer ...

Hoffmann has been vice-chair of Roche since 2006 and a board director since 1996. Among many other roles, he is a trustee of ...

Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Roche's core research spans five large areas. Boris Zaïtra, who now leads corporate business development, is confident his ...

Michael Tyler Roberts: Roberts, of Knoxville, was sentenced in December to 15 months in prison and three years of supervised ...

Discover the latest news and updates on Roche Diagnostics with insights on their Silicon Valley campus facade.

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received 510(k) clearance from the United States Food and Drug ...

The rise of GLP-1s have made treating obesity one of the largest market opportunities in history. It also has reinforced a ...

J.P. Morgan analyst Richard Vosser maintained a Sell rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of ...

Get ready to laugh with South Florida’s Comedy Calendar featuring special guest Dean Gonzalez! This week, we spotlight the top comedy shows in South Florida, including stand-up events at the Miami ...